These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 8559442

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Prenatal screening for Down's syndrome with use of maternal serum markers.
    Haddow JE, Palomaki GE, Knight GJ, Williams J, Pulkkinen A, Canick JA, Saller DN, Bowers GB.
    N Engl J Med; 1992 Aug 27; 327(9):588-93. PubMed ID: 1379344
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS, Haverkamp AD, Stark CF, Haverkamp C, Barth CK.
    J Matern Fetal Med; 1996 Aug 27; 5(2):70-3. PubMed ID: 8796771
    [Abstract] [Full Text] [Related]

  • 6. Effectiveness of combining maternal serum alpha-fetoprotein and hCG in a second-trimester screening program for Down syndrome.
    Mooney RA, Peterson CJ, French CA, Saller DN, Arvan DA.
    Obstet Gynecol; 1994 Aug 27; 84(2):298-303. PubMed ID: 7518896
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Preliminary evidence for associations between second-trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies.
    Benn PA.
    Prenat Diagn; 1998 Apr 27; 18(4):319-24. PubMed ID: 9602476
    [Abstract] [Full Text] [Related]

  • 9. Maternal serum screening.
    Carroll JC.
    Can Fam Physician; 1994 Oct 27; 40():1756-64. PubMed ID: 7524838
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Evaluation of Down's syndrome screening methods using maternal serum biochemistry in the second trimester pregnancy].
    Yu DY, Fu P, Zhang ZH, Wang F, Han MY, Ren HY, Zhao W, Zhang K, Li S, Jiang N.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Jun 27; 28(3):332-5. PubMed ID: 21644235
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Age-independent indices in second-trimester serum screening for Down's syndrome are useless.
    Zimmermann R, Reynolds TM, John R, Spencer K, Bartels I, Coombes E, Trevor S.
    Prenat Diagn; 1996 Jan 27; 16(1):79-82. PubMed ID: 8821858
    [Abstract] [Full Text] [Related]

  • 18. Second-trimester maternal serum screening for Down syndrome in in vitro fertilization pregnancies.
    Rice JD, McIntosh SF, Halstead AC.
    Prenat Diagn; 2005 Mar 27; 25(3):234-8. PubMed ID: 15791658
    [Abstract] [Full Text] [Related]

  • 19. Combining inhibin A with existing second-trimester markers in maternal serum screening for Down's syndrome.
    Cuckle HS, Holding S, Jones R, Groome NP, Wallace EM.
    Prenat Diagn; 1996 Dec 27; 16(12):1095-100. PubMed ID: 8994244
    [Abstract] [Full Text] [Related]

  • 20. First-trimester or second-trimester screening, or both, for Down's syndrome.
    Malone FD, Canick JA, Ball RH, Nyberg DA, Comstock CH, Bukowski R, Berkowitz RL, Gross SJ, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, Dukes K, Bianchi DW, Rudnicka AR, Hackshaw AK, Lambert-Messerlian G, Wald NJ, D'Alton ME, First- and Second-Trimester Evaluation of Risk (FASTER) Research Consortium.
    N Engl J Med; 2005 Nov 10; 353(19):2001-11. PubMed ID: 16282175
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.